Skip to main content
U.S. flag

An official website of the United States government

Return to Search

MM12804 - New Medicare Part B Immunosuppressant Drug Benefit

This revised Article comprises Subregulatory Guidance Make sure your billing staff knows about the new benefit effective January 1, 2023: Extension of Medicare coverage for immunosuppressant drugs beyond 36 months for certain patients with kidney transplants, Coverage of premiums and cost sharing for some of these patients. MLN Matters (MM) Articles are based on information contained within Change Requests (CRs). In this case, this article is based on content within CR 12804 that is posted on the CMS website at,,

Download the Guidance Document


Issued by: Centers for Medicare & Medicaid Services (CMS)

Issue Date: December 16, 2022

DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.